Company intelligence / Profile preview

LPixel

Chiyoda-ku, Tokyo, Japanlpixel.net ↗

Ownership: Private
Employees: ~42
Development stage: Commercial

Overview

LPixel has developed and commercialized advanced AI-powered platforms for medical imaging diagnostics (EIRL) and life science research image analysis (IMACEL). These systems are used to assist clinicians with radiology/colonoscopy interpretation, detect cancers/diseases from images, improve efficiency in pharmaceutical R&D, and ensure integrity of scientific images. The company collaborates with leading academic institutions such as the University of Tokyo and National Cancer Center Japan. Clinical results include deployment in Japanese hospitals to reduce radiologist workload.

Modalities: DeviceNon-pharmacological therapy (AI-based diagnostic support)
Industry: Digital Health Medical Devices

Partnerships

Astellas Pharma (collaboration on AI system development for cell evaluation)

Beyond the preview

Go deeper on LPixel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LPixel.

Explore the full profile